| Feature | Specification |
|---|---|
| Unit Size | 1 vial (10 doses) |
| Specificity | αVβ3 Integrin receptor |
IVISense Integrin Receptor 680 fluorescent imaging probe for in vivo detection of αvβ3 integrin is a low molecular weight peptidomimetic antagonist coupled to a red fluorochrome. This validated, high affinity (Kd = 4.2 nM) fluorescent probe has improved circulation half-life and specificity over RDG peptide-based agents, with selectivity 5-20x for αvβ3 integrin, for precise detection of αvβ3 integrins. This integrin-targeted molecular imaging agent enables non-invasive imaging to better understand biological processes, and disease biology and progression.
Including IVISense Integrin Receptor 680 fluorescent agent in careful experimental design allows for multiplexing with other channels and/or imaging times, and can be paired with other probes to achieve maximum efficiency and flexibility in your imaging studies.
| Brand |
IVISense
|
|---|---|
| Fluorescent Agent Type |
Targeted
|
| Imaging Modality |
Fluorescence
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Specificity |
αVβ3 Integrin receptor
|
| Storage Conditions |
-30 to -16 °C
|
| Therapeutic Area |
Angiogenesis
Atherosclerosis
Cardiovascular
Inflammation
Oncology
Pulmonary
Vascular
|
| Unit Size |
1 vial (10 doses)
|
| Wave Length |
680 nm
|
Are you looking for resources, click on the resource type to explore further.
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...
We are here to answer your questions.